VRQOL in Cataract Patients During the COVID-19 Pandemic
NCT04468308 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 116
Last updated 2020-09-23
Summary
The aim of this questionnaire survey is to evaluate the improvement in vision-related quality of life before and after cataract surgery using the National Eye Institute Visual Function Questionnaire 25 and the delay of improvement in the COVID-19 pandemic.
Conditions
- Senile Cataract
Interventions
- OTHER
-
Questionnaire
Patients complete the National Eye Institute Visual Function Questionnaire 25 pre-operative, 1 month and 3 month postoperatively.
Sponsors & Collaborators
-
Medical University Innsbruck
lead OTHER
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-08
- Primary Completion
- 2021-03-31
- Completion
- 2021-03-31
Countries
- Austria
Study Locations
More Related Trials
-
Levofloxacin Ocular Implant for Ocular Surgery
NCT04682288 ·Status: COMPLETED ·Phase: PHASE1
-
Topical 0.4% Ketorolac and Vitreoretinal Surgery
NCT00576329 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Usefulness of Visuprime in Cataract Surgery
NCT06533995 ·Status: COMPLETED ·Phase: NA
-
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
NCT02951351 ·Status: COMPLETED ·Phase: NA
-
Time Serial Analysis on Preemptive Analgesia of Preoperative Topical Diclofenac and Ketorolac in Photorefractive Keratectomy(PRK)
NCT01761071 ·Status: COMPLETED ·Phase: PHASE3
-
Effect on Wound Healing of Vigamox Versus Cravit
NCT00840580 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Profile Comparison of Undiluted Intracameral Moxifloxacin vs. Levofloxacin in Cataract Surgery
NCT05741632 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
NCT04342988 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Prophylactic Ketorolac on CME After Cataract Surgery
NCT00335439 ·Status: COMPLETED ·Phase: NA
-
Patient Assessment of Topical Anesthetic Effectiveness for Intravitreal Injections
NCT01027611 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Sedation in Vitreoretinal Surgery
NCT04346095 ·Status: UNKNOWN ·Phase: PHASE4
-
Lidocaine Usage for Pupil Dilatation (Mydriasis)
NCT01170130 ·Status: COMPLETED ·Phase: NA
-
Postoperative Discomfort and Ocular Redness Following Phacoemulsification Surgery
NCT02558218 ·Status: COMPLETED ·Phase: NA
-
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
NCT00630019 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
NCT06164743 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
NCT06681688 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Ocular Penetration of Topical Tacrolimus Eye Drops
NCT02794610 ·Status: UNKNOWN ·Phase: NA
-
Intracameral Mydriasis Versus Topical Mydriasis in Cataract Surgery
NCT00690222 ·Status: TERMINATED ·Phase: NA
-
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
NCT00469690 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification
NCT01001806 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
NCT00853970 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Impact of Ocular Anesthetic Procedures in Ocular Blood Flow
NCT01840215 ·Status: COMPLETED
-
Comparison Mydriasis by Mydrane With Topical Drop Application
NCT04880928 ·Status: COMPLETED ·Phase: PHASE4
-
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients
NCT00347503 ·Status: COMPLETED ·Phase: PHASE4
-
Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%
NCT06539637 ·Status: RECRUITING ·Phase: EARLY_PHASE1